Ingalls & Snyder LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.4M | Sell |
139,627
-857
| -0.6% | -$190K | 1.07% | 21 |
|
|
2025
Q4 | $32.1M | Sell |
140,484
-4,543
| -3% | -$1.03M | 1.18% | 19 |
|
|
2025
Q3 | $33.6M | Buy |
145,027
+7,966
| +6% | +$1.62M | 1.1% | 17 |
|
|
2025
Q2 | $25.4M | Buy |
137,061
+344
| +0.3% | +$63.9K | 0.9% | 22 |
|
|
2025
Q1 | $28.6M | Sell |
136,717
-1,031
| -0.7% | -$200K | 0.94% | 19 |
|
|
2024
Q4 | $24.5M | Sell |
137,748
-1,892
| -1% | -$348K | 0.96% | 23 |
|
|
2024
Q3 | $27.6M | Sell |
139,640
-9,823
| -7% | -$1.83M | 1.08% | 20 |
|
|
2024
Q2 | $25.6M | Sell |
149,463
-2,516
| -2% | -$417K | 1.1% | 21 |
|
|
2024
Q1 | $27.7M | Sell |
151,979
-2,588
| -2% | -$446K | 1.22% | 17 |
|
|
2023
Q4 | $24M | Sell |
154,567
-9,198
| -6% | -$1.34M | 1.08% | 20 |
|
|
2023
Q3 | $24.4M | Sell |
163,765
-3,258
| -2% | -$478K | 1.18% | 19 |
|
|
2023
Q2 | $22.5M | Sell |
167,023
-1,363
| -0.8% | -$200K | 1.08% | 22 |
|
|
2023
Q1 | $26.8M | Sell |
168,386
-38
| -0% | -$5.81K | 1.38% | 14 |
|
|
2022
Q4 | $27.2M | Sell |
168,424
-1,837
| -1% | -$282K | 1.48% | 14 |
|
|
2022
Q3 | $22.9M | Sell |
170,261
-1,255
| -0.7% | -$180K | 1.28% | 17 |
|
|
2022
Q2 | $26.3M | Sell |
171,516
-2,594
| -1% | -$396K | 1.37% | 15 |
|
|
2022
Q1 | $28.2M | Sell |
174,110
-8,749
| -5% | -$1.27M | 1.26% | 17 |
|
|
2021
Q4 | $24.8M | Buy |
182,859
+3,044
| +2% | +$360K | 1.12% | 20 |
|
|
2021
Q3 | $19.4M | Sell |
179,815
-7,655
| -4% | -$875K | 0.89% | 29 |
|
|
2021
Q2 | $21.1M | Buy |
187,470
+549
| +0.3% | +$61.8K | 0.94% | 28 |
|
|
2021
Q1 | $20.2M | Buy |
186,921
+5,804
| +3% | +$621K | 0.94% | 28 |
|
|
2020
Q4 | $19.4M | Buy |
181,117
+9,569
| +6% | +$920K | 0.96% | 28 |
|
|
2020
Q3 | $15M | Buy |
171,548
+15,421
| +10% | +$1.45M | 1.03% | 23 |
|
|
2020
Q2 | $15.3M | Buy |
156,127
+11,158
| +8% | +$982K | 0.88% | 32 |
|
|
2020
Q1 | $11M | Buy |
144,969
+23,562
| +19% | +$2.01M | 0.74% | 38 |
|
|
2019
Q4 | $10.7M | Sell |
121,407
-1,115
| -0.9% | -$92.6K | 0.58% | 44 |
|
|
2019
Q3 | $9.28M | Buy |
122,522
+51,946
| +74% | +$3.56M | 0.45% | 61 |
|
|
2019
Q2 | $5.13M | Sell |
70,576
-45,468
| -39% | -$3.57M | 0.25% | 88 |
|
|
2019
Q1 | $9.35M | Buy |
116,044
+2,733
| +2% | +$224K | 0.45% | 61 |
|
|
2018
Q4 | $10.4M | Sell |
113,311
-2,953
| -3% | -$260K | 0.55% | 45 |
|
|
2018
Q3 | $11M | Sell |
116,264
-1,164
| -1% | -$110K | 0.46% | 59 |
|
|
2018
Q2 | $10.9M | Sell |
117,428
-1,795
| -2% | -$175K | 0.5% | 54 |
|
|
2018
Q1 | $11.3M | Buy |
119,223
+677
| +0.6% | +$74.4K | 0.55% | 47 |
|
|
2017
Q4 | $11.5M | Sell |
118,546
-918
| -0.8% | -$86.5K | 0.53% | 50 |
|
|
2017
Q3 | $10.6M | Buy |
119,464
+44,054
| +58% | +$3.35M | 0.55% | 44 |
|
|
2017
Q2 | $5.47M | Buy |
75,410
+1,254
| +2% | +$84.3K | 0.3% | 70 |
|
|
2017
Q1 | $4.83M | Buy |
74,156
+1,517
| +2% | +$95.4K | 0.26% | 74 |
|
|
2016
Q4 | $4.55M | Sell |
72,639
-25,575
| -26% | -$1.56M | 0.25% | 82 |
|
|
2016
Q3 | $6.19M | Sell |
98,214
-3,848
| -4% | -$249K | 0.35% | 62 |
|
|
2016
Q2 | $6.32M | Buy |
102,062
+964
| +1% | +$58.7K | 0.37% | 57 |
|
|
2016
Q1 | $5.77M | Sell |
101,098
-3,791
| -4% | -$211K | 0.37% | 55 |
|
|
2015
Q4 | $6.21M | Buy |
104,889
+23,677
| +29% | +$1.36M | 0.4% | 54 |
|
|
2015
Q3 | $4.42M | Buy |
81,212
+394
| +0.5% | +$25.6K | 0.29% | 69 |
|
|
2015
Q2 | $5.43M | Sell |
80,818
-1,531
| -2% | -$100K | 0.3% | 69 |
|
|
2015
Q1 | $4.82M | Sell |
82,349
-13,213
| -14% | -$798K | 0.27% | 71 |
|
|
2014
Q4 | $6.25M | Sell |
95,562
-1,788
| -2% | -$113K | 0.36% | 60 |
|
|
2014
Q3 | $5.62M | Sell |
97,350
-502
| -0.5% | -$27.9K | 0.3% | 63 |
|
|
2014
Q2 | $5.52M | Sell |
97,852
-300
| -0.3% | -$15.7K | 0.27% | 71 |
|
|
2014
Q1 | $5.04M | Buy |
98,152
+11
| +0% | +$556 | 0.27% | 71 |
|
|
2013
Q4 | $5.18M | Sell |
98,141
-770
| -0.8% | -$37.8K | 0.29% | 66 |
|
|
2013
Q3 | $4.42M | Sell |
98,911
-2,740
| -3% | -$121K | 0.26% | 70 |
|
|
2013
Q2 | $4.2M | Buy |
+101,651
| New | +$4.45M | 0.27% | 71 |
|
Other funds holding ABBV
VCM
VPM
Ingalls & Snyder LLC's ABBV Position: Q1 2026 in Review
Ingalls & Snyder LLC reduced its AbbVie (ABBV) stake by 0.61% in Q1 2026, selling an estimated $190K and leaving 139,627 shares worth $30.4M. The position accounts for 1.07% of the portfolio, ranked #21.
Ingalls & Snyder LLC first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $33.6M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Ingalls & Snyder LLC held 139,627 shares of AbbVie worth $30.4M as of Q1 2026.
- Ingalls & Snyder LLC sold 857 AbbVie shares in Q1 2026, an estimated $190K.
- AbbVie made up 1.07% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #21 holding.
- Ingalls & Snyder LLC first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Ingalls & Snyder LLC's AbbVie position peaked at $33.6M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.